Britain ' s Destiny Pharma Raises Cash to Fund ' Superbug ' Drugs Britain ' s Destiny Pharma Raises Cash to Fund ' Superbug ' Drugs

Britain ' s Destiny Pharma, which is developing drugs to target antibiotic-resistant bacterial infections, has raised 15.3 million pounds ($19.8 million) by listing shares on London ' s AIM market.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news